4
Changes in Ownership
DEXCOM INC Filed Acc 0001093557-25-000018
EVP, Strategy & Corporate Dev sold 1,183 shares at $86.91 ($102,820)
- EVP, Strategy & Corporate Dev acquired 3,048 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Dolan Matthew Vincent · EVP, Strategy & Corporate Dev
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-01-28 | Grant or award : show line 1 in the form | +3,048 | 43,227 | D | ||
| 2025-01-29 | Sale : show line 2 in the form | −1,183 | $86.91 | $102,820 | 42,044 | D |
| Open-market sales · 1,183 sh · avg $86.91 · $102,820 | ||||||
Loading xslF345X05/wk-form4_1738280660.xml…